Recurrent and persistent vulvovaginal candidiasis: treatment with ketoconazole.
Obstet Gynecol
; 66(2): 248-54, 1985 Aug.
Article
em En
| MEDLINE
| ID: mdl-3895074
Forty-two women were administered ketoconazole, an orally absorbed antifungal agent. The symptoms of vulvar pruritus, burning, pain, and dysuria and the signs of vulvar erythema and fissures and vaginal erythema were associated with Candida albicans. Although ketoconazole relieved symptoms and signs seven days after therapy, a high recurrence rate occurred by 28 days after therapy.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Candidíase Vulvovaginal
/
Cetoconazol
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Limite:
Adult
/
Female
/
Humans
/
Middle aged
Idioma:
En
Ano de publicação:
1985
Tipo de documento:
Article